Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial
Clicks: 220
ID: 271774
2005
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
This is the first randomized-controlled trial evidence that S. boulardii effectively reduces the risk of antibiotic-associated diarrhoea in children.| Reference Key |
m2005alimentarysaccharomyces
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Kotowska M;Albrecht P;Szajewska H;; |
| Journal | alimentary pharmacology & therapeutics |
| Year | 2005 |
| DOI | DOI not found |
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
treatment outcome
female
male
adolescent
Child
Infant
preschool
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
diarrhea / prevention & control*
anti-bacterial agents / adverse effects*
probiotics / therapeutic use*
saccharomyces*
pmid:15740542
doi:10.1111/j.1365-2036.2005.02356.x
m kotowska
p albrecht
h szajewska
diarrhea / chemically induced
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.